Agent Orange Exposure Doubles Prostate Cancer Risk
Tuesday, June 10th, 2008 Posted in prostate cancer risks | No Comments »Researchers presenting their findings at the American Urological Association's Annual Meeting say there is a definite correlation between Agent Orange exposure and prostate cancer risk for Vietnam vets. Lead researcher Dr. Karim Chamie said that the new analysis was based on ...
OHSU tests new prostate cancer drug
Sunday, June 8th, 2008 Posted in prostate cancer | No Comments »The MDV3100 drug shows great promise in the treatment of prostate cancer. The first human trials on the drug are underway at Oregon Health Sciences University. Researchers say they're learning more than ever about the biology of prostate cancer. They know ...
June is Prostate Cancer Awareness Month
Saturday, June 7th, 2008 Posted in prostate cancer | No Comments »June is Prostate Cancer Awareness Month and men should become aware of the risks and become informed on the effectiveness of screening. Prostate cancer is the third leading cancer killer of men in the United States. Nearly 186,000 new cases will ...
Trial Tests new Procedure for Prostate Cancer Patients
Friday, June 6th, 2008 Posted in prostate cryotherapy | No Comments »For prostate cancer patients who fail radiation therapy, there have not been many treatment choices. A major clinical trial is underway to test a procedure to freeze cancerous cells called Salvage Cryo Therapy.The University of Colorado Cancer Center is the ...
Bavarian Nordic enters trials with prostate cancer vaccine
Wednesday, June 4th, 2008 Posted in prostate cancer prevention | No Comments »Bavarian Nordic's subsidiary, BN ImmunoTherapeutics has initiated Phase I/II clinical studies with its therapeutic vaccine candidate against prostate cancer. A Phase I/II safety and tolerability study in 18 male patients with non-metastatic as well as hormone-insensitive prostate cancer has begun enrolment ...
Androgen therapy does extend survival time for patients, but it isn’t a cure
Tuesday, June 3rd, 2008 Posted in hormone therapy | No Comments »U.S. researchers at Seattle's Fred Hutchinson Cancer Research Center have unc overed that androgen therapy, which involves the use of surgical castration or medical castration with testosterone-blocking drugs, does extend survival time for patients, but it isn't a cure. Eventually, ...
How Advanced Prostate Cancer Becomes Resistant To Androgen-deprivation Therapy
Monday, June 2nd, 2008 Posted in hormone therapy | No Comments »For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone -- the hormone that fuels prostate-cancer growth -- via surgical castration (orchiectomy) or medical castration ...
New chemo drug effective in treating prostate cancer
Sunday, June 1st, 2008 Posted in prostate chemotherapy | No Comments »A research team at the Oregon Health and Science University have found a new chemotherapy drug, called Sagopilone, that may help treat prostate cancer. This is a new class of drug that inhibits growth and the spread of malignant cell, similar to ...